Natural Grocers Boldly Going Where Others Have Gone Before [View article]
Then I assume you must also hate advertising. "Spending millions of dollars telling people to buy a product - when some of them will just ignore it or fast-forward their DVR!"
Natural Grocers Boldly Going Where Others Have Gone Before [View article]
sstromberg - what has your experience with their nutritionist(s) been like? Are they oriented towards pushing/selling what they have in-store, or do they approach things in a more "holistic" approach?
Natural Grocers Boldly Going Where Others Have Gone Before [View article]
Turner, I got that number from an investor presentation made by UNFI (a distributor of organic/natural foods) a little while ago. I've also seen a couple of sell-side analysts corroborate the $90B-$100B number, but I have not yet seen a specific breakdown by segment.
It's not inconceivable that the difference between your $30B and the $90B is triple counting at the production, distribution, and retailing level.
I found this link that refers to a $90B number from "Natural Foods Merchandiser" that includes natural/organic food and supplements, so I'd say that's probably the number that people are using/repeating.
Red-Hot Novadaq Shows There's Green In Being Green [View article]
Perhaps I wasn't sufficiently clear "Whassup44", but my valuation was based upon a DCF, not a price or ev/sales methodology.
If you want to go w/ discounted price/sales, assigning a 6x multiple to 2022 rev (750M) and discounting it back would imply a value around $40/sh. A 4x multiple (which would seem more appropriate given where the company's growth rate would be in 2022) would give you a $27 target.
Red-Hot Novadaq Shows There's Green In Being Green [View article]
Huthutho -
What you heard from that surgeon is pretty common and consistent with newer technologies. Older surgeons always say that the good surgeons don't need whatever the new technology offers. Given the reductions in complications, though, I think it's harder to make the case that even great surgeons can adequately assess perfusion (or at least that's the bull argument for NVDQ).
And I agree about ISRG being a potential buyer - if Pinpoint takes off, I could see them even more motivated to buy it and prevent COV/SYK from gaining/keep share in min-invasive procedures.
Solta Has The Chance To Rejuvenate Itself [View article]
Oh I completely agree, Paul. But then I think the whole non-reconstructive aesthetics space is underpinned by some pretty weird "logic" when it comes to the customers! lol
Solta Has The Chance To Rejuvenate Itself [View article]
Paul, with respect, I think it's misleading to compare Liposonix to going to the gym. From my DD calls, the Liposonix customer base is pretty much those people who want to fit into a particular set of clothing by a fixed date and don't have the time/discipline/confid... to go the route of diet/exercise.
I'm also not sure I'd agree with you about the CYNO lipo technology, nor the economies of scale from the PMTI deal. I see the PMTI deal as much more about securing/acquiring the best IP estate in the laser/energy space.
Moreover, you're wrong in part about comparing Altera and Microsemi. MSCC did acquire a PLD business when it bought Actel. It's a small business and their share is tiny relative to Altera, but they compete nevertheless.
I was comparing the addressed end markets (industrial, defense/aero, communications), not the products. Notice the "as well as other chip suppliers with similar end-market exposures." phrase after the comparison to Altera.
Natural Grocers Boldly Going Where Others Have Gone Before [View article]
Natural Grocers Boldly Going Where Others Have Gone Before [View article]
Natural Grocers Boldly Going Where Others Have Gone Before [View article]
Natural Grocers Boldly Going Where Others Have Gone Before [View article]
Natural Grocers Boldly Going Where Others Have Gone Before [View article]
It's not inconceivable that the difference between your $30B and the $90B is triple counting at the production, distribution, and retailing level.
I found this link that refers to a $90B number from "Natural Foods Merchandiser" that includes natural/organic food and supplements, so I'd say that's probably the number that people are using/repeating.
http://dmreg.co/18IDmTN
Natural Grocers Boldly Going Where Others Have Gone Before [View article]
Red-Hot Novadaq Shows There's Green In Being Green [View article]
Red-Hot Novadaq Shows There's Green In Being Green [View article]
If you want to go w/ discounted price/sales, assigning a 6x multiple to 2022 rev (750M) and discounting it back would imply a value around $40/sh. A 4x multiple (which would seem more appropriate given where the company's growth rate would be in 2022) would give you a $27 target.
Red-Hot Novadaq Shows There's Green In Being Green [View article]
What you heard from that surgeon is pretty common and consistent with newer technologies. Older surgeons always say that the good surgeons don't need whatever the new technology offers. Given the reductions in complications, though, I think it's harder to make the case that even great surgeons can adequately assess perfusion (or at least that's the bull argument for NVDQ).
And I agree about ISRG being a potential buyer - if Pinpoint takes off, I could see them even more motivated to buy it and prevent COV/SYK from gaining/keep share in min-invasive procedures.
If MSC Industrial Doesn't Beat, What Does It Say About The Business? [View article]
Not so sure about FAST. Definitely less than 25%.
Solta Has The Chance To Rejuvenate Itself [View article]
Solta Has The Chance To Rejuvenate Itself [View article]
I'm also not sure I'd agree with you about the CYNO lipo technology, nor the economies of scale from the PMTI deal. I see the PMTI deal as much more about securing/acquiring the best IP estate in the laser/energy space.
Microsemi Offers Underrated Potential [View article]
Microsemi Offers Underrated Potential [View article]
ExactTarget Needs A Decade Of Exceptional Growth To Hit Its Targets [View article]